Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland

Multiple myeloma is a malignant disease characterised by the clonal proliferation of plasma cells. Since the last update of the Swiss recommendations for the diagnosis and treatment of multiple myeloma in 2019, the therapeutic landscape has evolved significantly, with the development of new monoclonal antibodies, novel combination therapies, and the introduction of T-cell-redirecting treatments such as bispecific antibodies and CAR T-cell therapy. This article summarises the current diagnostic procedures and therapeutic recommendations in Switzerland.

Authors

Institutions

Publication Details

Journal
Swiss Medical Weekly
Published
2025-10-23
DOI
https://doi.org/10.57187/s.4252
Primary Topic
Multiple Myeloma Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland

Veronika Ballová, Barbara Jeker, Erika Lerch, Christoph Driessen et al.
Swiss Medical Weekly
Multiple Myeloma Research and Treatments
article

Updated recommendations for diagnosis and treatment of multiple myeloma in Switzerland

Veronika Ballová, Barbara Jeker, Erika Lerch, Christoph Driessen, Thilo Zander, Carmen De Ramón Ortiz, Ulrich Mey, Thomas Pabst, Martina Bertschinger, Holger W. Auner, Rouven Müller, Dominik Heim, Sabine Gerull, Panagiotis Samaras, Adrian Schmidt, Christoph Renner, Christian Taverna
article en

Abstract

Multiple myeloma is a malignant disease characterised by the clonal proliferation of plasma cells. Since the last update of the Swiss recommendations for the diagnosis and treatment of multiple myeloma in 2019, the therapeutic landscape has evolved significantly, with the development of new monoclonal antibodies, novel combination therapies, and the introduction of T-cell-redirecting treatments such as bispecific antibodies and CAR T-cell therapy. This article summarises the current diagnostic procedures and therapeutic recommendations in Switzerland.

Swiss Medical WeeklyVol. 155(10)
University of Lucerne (CH), University of St.Gallen (CH), Triemli Hospital (CH), University Hospital of Bern (CH), University Hospital of Basel (CH), Ospedale San Giovanni Bellinzona (CH), Klinik Hirslanden (CH), Kantonsspital Winterthur (CH), University Hospital of Zurich (CH), University Hospital of Geneva (CH), Center for Pediatric Endocrinology Zurich (CH), Kantonsspital Münsterlingen (CH), Kantonsspital Baden (CH), Kantonsspital Graubünden (CH), Kantonsspital Aarau (CH), University of Lausanne (CH)
Openalex Percentile: Top 61%
Multiple Myeloma Research and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.